Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001084652 | SCV000629250 | benign | Pityriasis rubra pilaris; Psoriasis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262615 | SCV002543299 | likely benign | Autoinflammatory syndrome | 2021-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000059697 | SCV004146307 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CARD14: BS1, BS2 |
Prevention |
RCV003915027 | SCV004736327 | benign | CARD14-related disorder | 2020-04-16 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Uni |
RCV000059697 | SCV000091267 | not provided | not provided | no assertion provided | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000059697 | SCV001798978 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000059697 | SCV001931872 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000059697 | SCV001970090 | likely benign | not provided | no assertion criteria provided | clinical testing |